EVLO - Evelo Biosciences Inc. (EVLO) CEO Simba Gill On Q4 2021 Results - Earnings Call Transcript
Evelo Biosciences, Inc. (EVLO) Q4 2021 Earnings Conference Call March 24, 2022 8:30 AM ET Company Participants Kendra Sweeney - Investor Relations Simba Gill - Chief Executive Officer Mark Bodmer - President of R&D, Chief Scientific Officer Jonathan Zung - Chief Development Officer Conference Call Participants Chris Howerton - Jefferies Gary Nachman - BMO Capital Markets Joseph Thome - Cowen Kristen Kluska - Cantor Gospel Asonye - Morgan Stanley Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:04 Good morning and welcome to Evelo Biosciences Conference Call to discuss its Fourth Quarter and Full-Year 2021 Business Highlights. At this time, all participants are in a listen-only mode. Following
For further details see:
Evelo Biosciences, Inc. (EVLO) CEO Simba Gill On Q4 2021 Results - Earnings Call Transcript